Global TIL Therapy Market is Segmented By Therapy Type (Autologous TIL Therapy, Allogeneic TIL Therapy), By Cancer Type (Melanom, Cervical Cancer, Bre....
Market Size in USD
CAGR39.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 39.3% |
Market Concentration | High |
Major Players | Iovance Biotherapeutics, Instil Bio, Obsidian Therapeutics, Cellectis, Cellular Biomedicine Group |
The Global TIL Therapy Market is estimated to be valued at USD 0.092 Billion in 2024 and is expected to reach USD 9.20 Billion by 2031, growing at a compound annual growth rate (CAGR) of 39.3% from 2024 to 2031. TIL therapy is an emerging and promising treatment for certain types of cancers like melanoma. The demand for TIL therapy is expected to grow significantly during the forecast period due to ongoing research and increasing awareness.
The market is witnessing positive trends that are expected to drive the growth during the forecast period. Since TIL therapy is still new, ongoing clinical trials will help understand its potential better and drive its adoption. Moreover, growing cancer incidence rates will also boost the need for advanced treatment options like TIL therapy worldwide. However, high costs associated with the therapy and lack of expertise may limit the market potential in the coming years.